title: Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic Patients.
abstract: The determination of the underlying etiology of symptoms suggestive of obstructive coronary artery disease (CAD, ≥50% stenosis in a major coronary artery) is a common clinical challenge in both primary care and cardiology clinics. Usual care in low to medium risk patients often involves a family history, risk factor assessment, and then stress testing with or without non-invasive imaging. If positive, this is often followed by invasive coronary angiography (ICA). Despite extensive adoption of this usual care paradigm, more than 60% of patients referred for angiography do not have obstructive CAD. In order to robustly identify those symptomatic patients without obstructive CAD, who can avoid subsequent cardiac testing and look elsewhere for the cause of their symptoms, a recently described whole blood gene expression score (GES: Corus® CAD, CardioDx, Inc., Palo Alto, CA) has been developed and validated in two multi-center trials. This paper reviews the published literature and assessments by independent parties regarding the analytical and clinical validity as well as the clinical utility of the Corus® CAD test.
authors.affiliation: MedStar Georgetown University Hospital, Washington, DC, USA.
authors.forename: Jose
authors.initials: J
authors.lastname: Vargas
authors.forename: Joao A C
authors.initials: JA
authors.lastname: Lima
authors.forename: William E
authors.initials: WE
authors.lastname: Kraus
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Douglas
authors.forename: Steven
authors.initials: S
authors.lastname: Rosenberg
references.citation: Br J Gen Pract. 2003 May;53(490):378-82
references.pmid: 12830565
references.citation: Ann Intern Med. 2010 Oct 5;153(7):425-34
references.pmid: 20921541
references.citation: Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):182-95
references.pmid: 22258901
references.citation: J Cardiovasc Transl Res. 2012 Jun;5(3):366-74
references.pmid: 22396313
references.citation: BMC Med Genomics. 2011 Mar 28;4:26
references.pmid: 21443790
references.citation: Circulation. 2005 Mar 15;111(10):1313-20
references.pmid: 15769774
references.citation: Am Heart J. 2012 Sep;164(3):320-6
references.pmid: 22980297
references.citation: J Cardiovasc Comput Tomogr. 2009 Jan-Feb;3(1):16-21
references.pmid: 19201372
references.citation: Am J Cardiol. 1999 Mar 1;83(5):660-6
references.pmid: 10080415
references.citation: Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1682-6
references.pmid: 17634522
references.citation: Nat Rev Cardiol. 2013 May;10(5):243-4
references.pmid: 23546447
references.citation: Circulation. 2012 Jul 3;126(1):142-57
references.pmid: 22645291
references.citation: Can Fam Physician. 2007 Feb;53(2):261-6
references.pmid: 17872643
references.citation: JAMA. 2008 Oct 15;300(15):1765-73
references.pmid: 18854538
references.citation: Crit Pathw Cardiol. 2013 Jun;12(2):37-42
references.pmid: 23680805
references.citation: PLoS One. 2012;7(7):e40068
references.pmid: 22802952
references.citation: Circulation. 2011 Jul 5;124(1):87-94
references.pmid: 21730321
references.citation: J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164
references.pmid: 23182125
references.citation: Am Fam Physician. 2005 Nov 15;72(10):2012-21
references.pmid: 16342831
references.citation: Genet Med. 2009 Jan;11(1):3-14
references.pmid: 18813139
references.citation: N Engl J Med. 2010 Mar 11;362(10):886-95
references.pmid: 20220183
references.citation: Circ Cardiovasc Genet. 2013 Apr;6(2):154-62
references.pmid: 23418288
references.citation: J Am Coll Cardiol. 2013 Mar 12;61(10):1054-65
references.pmid: 23473411